30
Participants
Start Date
January 21, 2025
Primary Completion Date
February 17, 2025
Study Completion Date
February 17, 2025
Zidebactam-Cefepime
(1) ZID-FEP 3g IV (ZID 1 g plus FEP 2 g) administered over 1 hour (h)
Metronidazole
(2) metronidazole 0.5 g IV alone administered over 1 h
FEP-ZID
(3) metronidazole 0.5 g IV over 1 h, followed by ZID-FEP 3g IV over 1 h over 3 treatment periods separated by a 48 h washout period.
Advanced Pharma CR, LLC, Miami
Lead Sponsor
Collaborators (1)
Eric Solutions LLC
UNKNOWN
Wockhardt
INDUSTRY